Compare Gemini Space Station Inc (GEMI) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Gemini Space Station Inc trades at $4.4 (market cap $579.55M), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 21.7× Gemini Space Station Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GEMI | HALO | |
|---|---|---|
Market Cap | $579.55M | $12.58B |
Volume | 1,882,406 | 2,179,278 |
Sector | Financials | Health |
52-Week High | $25.41 | $115.22 |
52-Week Low | $3.54 | $61.63 |
Typical Hold Time | 14 Days | 1 Days |
Enterprise Value | $558.57M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.395, down 2.12% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue growth of 37% year-over-year but missed earnings estimates with a net loss of -$0.89 per share. Despite negative profitability margins, analyst consensus price target is $5.25 with 33% buy ratings. Recent news highlights expansion into commission-free stock trading and ongoing securities litigation.
The stock faces significant fundamental challenges with negative profit margins and cash burn, though revenue growth and new business initiatives provide potential catalysts. High volatility and legal risks weigh on investor sentiment, creating a speculative opportunity for those betting on the company's super app strategy amid cautious Wall Street coverage.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
